Journal of the National Cancer Institute
Physical activity and molecular residual disease in stage III colon cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80702
Trial in 763 peoplePopulations
6.0 years, cohort study
The paper
Brigham and Women's Hospital; Dana-Farber Cancer Institute
Journal of the National Cancer Institute, 24 Sep 2026


